资讯
Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response ...
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...
Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...
While AbbVie handily beat expectations this quarter, the company faces declining Humira sales and a challenged aesthetics ...
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.
A 25% tariff on pharmaceutical imports may increase U.S. drug costs by $51 billion annually, raising prices by 12.9%. The U.S. imported $203 billion in pharmaceuticals in 2023, mainly from Europe. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果